NASDAQ : COSM
Cosmos Health Inc. — Key statistics
Healthcare · Medical Distribution · United States
Last price 0.2775 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 27.93M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 30.99M |
| Enterprise Value | 45.12M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 100.63M |
| Shares Outstanding | 100.63M |
| Shares Change (YoY) | +78.05% |
| Shares Change (QoQ) | +27.26% |
| Owned by Insiders (%) | 24.31% |
| Owned by Institutions (%) | 8.77% |
| Float | 76.17M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 8.80 |
| PS Ratio | 0.42 |
| Forward PS | 0.28 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.05 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.91 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -104.00% |
| Return on Assets (ROA) | -18.42% |
| Return on Invested Capital (ROIC) | -50.82% |
| Return on Capital Employed (ROCE) | -68.27% |
| Weighted Average Cost of Capital (WACC) | 24.32% |
| Revenue Per Employee | $452,318 |
| Profits Per Employee | -$149,637 |
| Employee Count | 163 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 13.74 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 4.21 |
| 52-Week Price Change | -66.76% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (20 Days) | 2,601,824 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.29M |
| Short Previous Month | 2.56M |
| Short % of Shares Out | 2.27% |
| Short % of Float | 3.00% |
| Short Ratio (days to cover) | 0.57 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 73.73M |
| Gross Profit | 7.57M |
| Operating Income | -18.17M |
| Pretax Income | -24.39M |
| Net Income | -24.39M |
| EBITDA | -16.79M |
| EBIT | -18.17M |
| Loss Per Share | -$0.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.84M |
| Total Debt | 15.98M |
| Net Cash | -14.14M |
| Net Cash Per Share | -$0.14 |
| Equity (Book Value) | 20.67M |
| Book Value Per Share | 0.26 |
| Working Capital | 1.83M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -9.84M |
| Capital Expenditures | -95,647 |
| Depreciation & Amortization | 1.38M |
| Net Borrowing | 7.96M |
| Free Cash Flow | -9.93M |
| FCF Per Share | -$0.10 |
Margins
| Measure | Value |
|---|
| Gross Margin | 10.27% |
| Operating Margin | -24.65% |
| Pretax Margin | -33.08% |
| Profit Margin | -33.08% |
| EBITDA Margin | -22.77% |
| EBIT Margin | -24.65% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -78.05% |
| Shareholder Yield | -78.05% |
| Earnings Yield | -184.48% |
| FCF Yield | -32.06% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.95 |
| Price Target Difference | 858.10% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 35.05% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |